Currently, median age at start of GH treatment in short SGA children in Belgium is 7.7 years (data on file, Belgian Society for Pediatric Endocrinology and Diabetology (BESPEED)).
This registry collects coded data since 1985 and was approved by the Ethical Committees of the participating centres of the BESPEED members.
The authors would like to thank also the other members of BESPEED who contributed to the BELGROW registry (Belgian registry for patients treated with growth hormone): V.